Respiri Limited released its earnings results on Aug 27, 2024. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.

Q: Is Respiri Limited overvalued?

According to Wall Street analysts Respiri Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Respiri Limited have?

Respiri Limited has 1,334,275,400 shares outstanding.

Q: What happened to Respiri Limited’s price movement after its last earnings report?

Respiri Limited reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

5 Followers

RSHUF Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week Range<$0.01 - $0.09

Previous CloseN/A

Volume3.50K

Average Volume (3M)0.00

Market Cap

$63.61M

Enterprise Value$28.75M

Total Cash (Recent Filing)$1.56M

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-27.97

Next Earnings

Feb 26, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,334,275,400

10 Day Avg. Volume0

30 Day Avg. Volume0

Standard Deviation7.89

R-Squared0.02

Alpha1.29

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)290.78

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market Cap0.45

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-5.13K

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Respiri Limited News

PremiumCompany Announcements

Respiri Limited Announces New Securities Issuance

12d ago

PremiumCompany Announcements

Respiri Limited Successfully Concludes Shareholder Meeting with All Resolutions Passed

14d ago

PremiumCompany Announcements

Respiri Limited Announces Virtual General Meeting in 2025

2M ago

PremiumCompany Announcements

Respiri Limited to Discuss Orb Health Acquisition

2M ago

PremiumCompany Announcements

Respiri Limited Announces Major Share Quotation on ASX

2M ago

PremiumCompany Announcements

Respiri Limited to Highlight Innovations in Respiratory Healthcare

2M ago

PremiumCompany Announcements

Respiri Limited Expands with Orb Health Acquisition

2M ago

PremiumCompany Announcements

Respiri Limited Initiates Trading Halt for Acquisition News

2M ago

See More RSHUF News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

1.22% Insiders

― Mutual Funds

― Other Institutional Investors

98.78% Public Companies and

Individual Investors

Detailed Ownership Overview >

RSHUF FAQ

What was Respiri Limited’s price range in the past 12 months?

Respiri Limited lowest stock price was <$0.01 and its highest was $0.09 in the past 12 months.

What is Respiri Limited’s market cap?

Respiri Limited’s market cap is $63.61M.

When is Respiri Limited’s upcoming earnings report date?

Respiri Limited’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.

How were Respiri Limited’s earnings last quarter?

Respiri Limited released its earnings results on Aug 27, 2024. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.

Is Respiri Limited overvalued?

According to Wall Street analysts Respiri Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Respiri Limited pay dividends?

Respiri Limited does not currently pay dividends.

What is Respiri Limited’s EPS estimate?

Respiri Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Respiri Limited have?

Respiri Limited has 1,334,275,400 shares outstanding.

What happened to Respiri Limited’s price movement after its last earnings report?

Respiri Limited reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Respiri Limited?

Currently, no hedge funds are holding shares in RSHUF

---

Respiri Limited Stock Smart Score

Unlock Smart Score

Fundamentals

Return on Equity

-404.41%

Trailing 12-Months

Asset Growth

95.25%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Respiri Limited

Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. It operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.

---